Endogest AQ 25 Injection

Composition Progesterone (25mg/ml)
Rx Prescription Required
Pack vial of 1.119 ml Injection
Storage Store below 30°C
Chemical Class Progesterone Derivative
Action Class Natural Progesterone
Habbit Forming
Manufacturer Cipla Ltd
Manufacturer address Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Endogest AQ 25 Injection provides progesterone, which is a natural hormone essential for reproductive health. It is used to support pregnancy in female infertility and as part of hormone replacement therapy. It helps regulate the menstrual cycle, prepares the uterus for pregnancy, and balances hormones.

You should use Endogest AQ 25 Injection as your doctor has advised. It is given as an injection by a healthcare professional. Do not exceed the prescribed dose or use it for longer than recommended. Your doctor may advise you to continue receiving this injection for a certain period after pregnancy is confirmed.

The most common side effects include headache, back pain, dizziness, weight gain, vaginal discharge, stomach cramps, pain or swelling in your abdomen, and feeling sick. You may also feel bloated, less interested in sex, and get pain or discharge in your vagina. Your doctor or nurse may be able to help you reduce or prevent side effects if they bother you or do not go away. Very occasionally, people get a severe allergic reaction that needs urgent medical attention.

Endogest AQ 25 Injection may not suit everybody, and you should tell your doctor if you have, or have had, breast cancer, unusual bleeding in the vagina, or liver disease. You may be monitored more carefully if you have liver, kidney, or heart problems, or have diabetes or asthma.

Let your doctor know your medical history. Check with your doctor about all other medicines that may affect, or be affected by, this medicine. You will probably have several tests both before and during treatment to check your womb. In general, alcohol is not recommended while taking this medicine.

Female infertility

Hormone replacement therapy

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Endogest AQ 25 Injection works by preparing the uterus for pregnancy and maintaining a healthy environment for fetal development. It thickens the uterine lining to support implantation and prevents contractions that could lead to early pregnancy loss. Additionally, it helps regulate the menstrual cycle and balances other reproductive hormones. In hormone therapy, it supports overall hormonal stability and helps manage symptoms related to hormonal imbalances.

Q: What if you forget to take Endogest Injection?
A: If you miss a dose of Endogest AQ 25 Injection, consult the doctor.

Do not self-administer unless advised. Only inject at home if your doctor has trained you properly.

Let your doctor know if you have any history of blood clots, breast cancer, or liver issues before starting treatment.

Your doctor may schedule hormone level tests or scans to monitor your response to treatment. Make sure to attend all scheduled appointments for best results.

Q. What is Endogest AQ 25 Injection?

Endogest AQ 25 Injection contains progesterone, which is a natural female sex hormone. It is used to treat menstrual and pregnancy-related issues that are caused by hormonal imbalances. It may also be prescribed along with estrogen as a part of hormonal replacement therapy for preventing endometrial hyperplasia (thickening of the lining of the uterus).

Q. What does Endogest AQ 25 Injection treat?

Endogest AQ 25 Injection is used to treat various disorders. It is given to women with secondary amenorrhea (no menstruation for 3 months in women who have had their menses before). It is used to support pregnancy, prevent premature labor, and treat bleeding disorders that may occur before menopause. It may be used as a part of fertility treatment and may be given as hormone replacement therapy after menopause. It is also given to relieve symptoms of premenstrual syndrome and painful bleeding, like dysfunctional uterine bleeding.

Q. How and in what dose should I take Endogest AQ 25 Injection?

Endogest AQ 25 Injection is to be given by a doctor or nurse only. It is given as an injection into the muscle. The dose will depend on the condition you are being treated for and will be decided by your doctor. Follow your doctor’s instructions carefully to get maximum benefit from Endogest AQ 25 Injection.

Q. Does Endogest AQ 25 Injection cause weight gain?

Yes, the use of Endogest AQ 25 Injection may cause weight gain. The reason for this weight gain could be water retention. However, this may not be a serious sign. If you are concerned about weight gain, contact your doctor.

Q. How is Endogest AQ 25 Injection beneficial for fertility and pregnancy?

Endogest AQ 25 Injection consists of progesterone, which is important for fertility. Progesterone is the hormone secreted by the ovaries that helps prepare the uterus for pregnancy and also maintains it. Endogest AQ 25 Injection is given in cases of infertility to support the uterus in preparing itself for the pregnancy and to prevent abortions in some cases. It is also used to prevent premature labor.

Q. Is Endogest AQ 25 Injection effective?

Endogest AQ 25 Injection is effective if used in the dose and duration advised by your doctor. Do not stop taking it even if you see improvement in your condition. If you stop using Endogest AQ 25 Injection too early, the symptoms may return or worsen.

In Female infertility

Endogest AQ 25 Injection contains progesterone, a female hormone that is important in the regulation of ovulation and menstruation. It is used to cause menstrual periods in women who have not reached menopause but are not having periods due to a lack of natural progesterone in the body. This medicine helps to prepare the uterus for pregnancy by causing the uterus lining (endometrium) to thicken. This increases the chance of a successful pregnancy. You should use the medicine as prescribed for it to be effective. You may be asked to continue with this treatment for a period after becoming pregnant.

Nervousness

Decreased libido

Anorgasmia (decreased orgasm)

Depression

Insomnia (difficulty in sleeping)

Headache

Dizziness

Flushing (sense of warmth in the face, ears, neck and trunk)

Abdominal pain

Abdominal discomfort

Abdominal distension

Nausea

Back pain

Leg cramps

Irregular uterine bleeding

Vaginal discharge

Breast pain

Breast tenderness

Pain during periods

Pelvic pain

Vaginal inflammation

Edema (swelling)

Weakness

Fatigue

Change in body weight

Alcohol:CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Endogest AQ 25 Injection. Please consult your doctor.

Pregnancy:UNSAFE

Endogest AQ 25 Injection is highly unsafe to use during pregnancy. Seek your doctor’s advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.

Breast feeding:CONSULT YOUR DOCTOR

Information regarding the use of Endogest AQ 25 Injection during breastfeeding is not available. Please consult your doctor.

Driving:UNSAFE

Endogest AQ 25 Injection may cause side effects which could affect your ability to drive.

Kidney:SAFE IF PRESCRIBED

Endogest AQ 25 Injection is safe to use in patients with kidney disease. No dose adjustment of Endogest AQ 25 Injection is recommended.

Liver:CONSULT YOUR DOCTOR

There is limited information available on the use of Endogest AQ 25 Injection in patients with liver disease. Please consult your doctor.Use of Endogest AQ 25 Injection is however not recommended in patients with severe liver disease.

Chrousos GP. The Gonadal Hormones & Inhibitors. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 706-707.
Levin ER, Hammes SR. Estrogens and Progestins. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1180-85.
Progesterone. Lodi, Italy: IBSA Farmaceutici Italia Srl; 2013. [Accessed 21 Jun. 2019] (online) Available from: View
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198. [Accessed 03 Apr. 2019] (online) Available from: View
Progesterone [Product Description]. Corona, CA: Watson Laboratories, Inc.; 2007. [Accessed 28 Mar. 2023] (online) Available from: View
Medroxyprogesterone acetate. Sandton, South Africa: Pfizer Laboratories (Pty) Ltd.; 2025. [Accessed 02 March. 2025] (online) Available from: View